RGC CEO Figuratively Putting His Money Where His Mouth Is
NEWS AND UPDATES RGC CEO Figuratively Putting His Money Where His Mouth Is Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to […]
Regencell Featured on ValueWalk
NEWS AND UPDATES Game-Stop Or Game-On? Regencell Has It All And Twice More Regencell Bioscience Limited’s (NASDAQ:RGC) stock is an undiscovered short squeeze potential. The short volume ratio has similar pattern as that of GameStop Corp. (NYSE:GME), whereby both averaged over 40% in the past year. In fact, RGC is more heavily shorted than GME as some […]
Regencell Featured on Benzinga
NEWS AND UPDATES Traders May Keep Hunting For Another “Squeezable” Stock Like Gamestop CEO Elon Musk recently claimed that Microsoft Corp. Co-Founder Bill Gates has a multibillion-dollar short position against his company. Musk suggested he doesn’t trust Gates and his stated commitment to addressing climate change, given his bets against Tesla. “Too often, sophisticated hedge funds have used […]
Over US$5 Million Ordinary Share Purchases by our CEO
NEWS AND UPDATES Over US$5 Million Ordinary Share Purchases by our CEO Mr. Yat-Gai Au, our Company’s Chairman and CEO, made purchases of ordinary shares in Regencell (“Ordinary Shares”) totaling $5.03 million. Based on his Schedule 13D filings with the U.S. Securities and Exchange Commission (the “SEC”) between July 27, 2021 and May 16, 2022, […]
Welcome Dr. William Wing-Yan Lo, JP to Become Our Board of Directors
NEWS AND UPDATES Welcome Dr. William Wing-Yan Lo, JP to Become Our Board of Directors We are delighted to have Dr. William Wing-Yan Lo, JP to become our Board of Directors, effective immediately. He is an excellent addition to our board as he brings a wealth of strategic and leadership experience. Welcome Dr Lo. […]
Over $1 Million Ordinary Share Purchase by our CEO
NEWS AND UPDATES Over $1 Million Ordinary Share Purchase by our CEO Yat-Gai Au, the Company’s Chairman & CEO, made Ordinary Share purchases of Regencell (“Ordinary Shares”) totaling US$1,125,807. As per the Schedule 13D filed with the SEC on November 22, 2021, Mr. Au has used an aggregate of US$1,125,807 of his personal funds to […]
Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
NEWS AND UPDATES Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index We announce that the ordinary shares of our Company will be added to the MSCI World Micro Cap Index on November 30, 2021 after the close of market (effective December 1, 2021). MSCI Inc., a leading provider of research-based indexes and analytics, […]
Our Interview on Benzinga’s Power Hour Show
NEWS AND UPDATES Our Interview on Benzinga’s Power Hour Show Our COO, James Chung & Independent Director, Paul Niewiadomski, appear on Benzinga’s Powerhour Show to discuss our recent developments and recent joint venture to provide COVID-19 and TCM treatment in ASEAN countries. Click to learn more: Benzinga
